Literature DB >> 12889819

Foot-and-mouth disease virus VP1 protein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast.

Meng Sun1, Kaixian Qian, Ning Su, Huiyun Chang, Jixing Liu, Guifang Shen, Guifang Chen.   

Abstract

A Chlamydomonas reinhardtii chloroplast expression vector, pACTBVP1, containing the fusion of the foot and mouth disease virus (FMDV) VP1 gene and the cholera toxin B subunit (CTB) gene was constructed and transfered to the chloroplast genome of C. reinhardtii by the biolistic method. The transformants were identified by PCR, Southern blot, Western blot and ELISA assays after selection on resistant medium and incubation in the dark. The CTBVP1 fusion protein was expressed in C. reinhardtii chloroplast and accounted for up to 3% of the total soluble protein. The fusion protein also retained both GM1-ganglioside binding affinity and antigenicity of the FMDV VP1 and CTB proteins. These experimental results support the possibility of using transgenic chloroplasts of green alga as a mucosal vaccine source.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12889819     DOI: 10.1023/a:1024140114505

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  33 in total

1.  Haematococcus as a promising cell factory to produce recombinant pharmaceutical proteins.

Authors:  Amir Ata Saei; Parisa Ghanbari; Abolfazl Barzegari
Journal:  Mol Biol Rep       Date:  2012-06-26       Impact factor: 2.316

Review 2.  Chlamydomonas reinhardtii: a protein expression system for pharmaceutical and biotechnological proteins.

Authors:  Christoph Griesbeck; Iris Kobl; Markus Heitzer
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

Review 3.  Photosynthetic biomanufacturing in green algae; production of recombinant proteins for industrial, nutritional, and medical uses.

Authors:  Beth A Rasala; Stephen P Mayfield
Journal:  Photosynth Res       Date:  2014-03-22       Impact factor: 3.573

4.  Microalgae as platforms for production of recombinant proteins and valuable compounds: progress and prospects.

Authors:  Yangmin Gong; Hanhua Hu; Yuan Gao; Xudong Xu; Hong Gao
Journal:  J Ind Microbiol Biotechnol       Date:  2011-09-01       Impact factor: 3.346

Review 5.  Manipulation of the microalgal chloroplast by genetic engineering for biotechnological utilization as a green biofactory.

Authors:  Yong Min Kwon; Kyung Woo Kim; Tae-Young Choi; Sun Young Kim; Jaoon Young Hwan Kim
Journal:  World J Microbiol Biotechnol       Date:  2018-11-26       Impact factor: 3.312

Review 6.  Microalgae as bioreactors.

Authors:  Tara L Walker; Saul Purton; Douglas K Becker; Chris Collet
Journal:  Plant Cell Rep       Date:  2005-08-31       Impact factor: 4.570

Review 7.  Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules.

Authors:  Isabelle Legastelois; Sophie Buffin; Isabelle Peubez; Charlotte Mignon; Régis Sodoyer; Bettina Werle
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

Review 8.  Chlamydomonas reinhardtii as a viable platform for the production of recombinant proteins: current status and perspectives.

Authors:  Sergio Rosales-Mendoza; Luz María Teresita Paz-Maldonado; Ruth Elena Soria-Guerra
Journal:  Plant Cell Rep       Date:  2011-11-12       Impact factor: 4.570

Review 9.  The green vaccine: A global strategy to combat infectious and autoimmune diseases.

Authors:  Abdoreza Davoodi-Semiromi; Nalapalli Samson; Henry Daniell
Journal:  Hum Vaccin       Date:  2009-07-23

10.  Robust expression and secretion of Xylanase1 in Chlamydomonas reinhardtii by fusion to a selection gene and processing with the FMDV 2A peptide.

Authors:  Beth A Rasala; Philip A Lee; Zhouxin Shen; Steven P Briggs; Michael Mendez; Stephen P Mayfield
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.